title: [Clinical types of immunologic transplant reactions following perforating keratoplasty].
abstract: The incidence of allograft rejection was determined for 740 penetrating keratoplasties performed between 1980 and 1987. All 740 cases were followed up for at least 1 year. The reaction forms of allograft rejection were grouped according to biomicroscopic appearance. The incidence and progression of symptoms are described. Rejection types are subdivided into patients with favorable versus poor prognosis. Of the patients 37.9% demonstrated an immune response (including discrete forms). Clear reaction patterns within the two groups of patients became apparent when reaction variations were carefully differentiated. Epithelial immune reaction was found in 5.2%/10.5% and subepithelial infiltration in 1.7%/4.8% of the patients with favorable/poor prognosis. The largest disparity in frequency occurred in progressive endothelial reaction; 3.8% in patients with favorable versus 36.7% in patients with poor prognosis. Focal endothelial reactions occurred in both groups with comparable frequencies (14.1%/13.3%). The large percentage of immunological reactions, including late manifestations (approximately 12% after 1 year) and some with irreversible progression, warrants continuing efforts to treat and prevent this complication.
authors.affiliation: Universitäts-Augenklinik, Tübingen.
authors.forename: U
authors.initials: U
authors.lastname: Pleyer
authors.forename: E G
authors.initials: EG
authors.lastname: Weidle
authors.forename: W
authors.initials: W
authors.lastname: Lisch
authors.forename: K P
authors.initials: KP
authors.lastname: Steuhl
authors.forename: C
authors.initials: C
authors.lastname: Möhrle
authors.forename: U
authors.initials: U
authors.lastname: Richter
authors.forename: M
authors.initials: M
authors.lastname: Zierhut
authors.forename: H K
authors.initials: HK
authors.lastname: Selbmann
mesh_terms: D003315:Cornea / Q000276:immunology*; D003316:Corneal Diseases / Q000601:surgery*; D003907:Dexamethasone / Q000008:administration & dosage; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D015948:Keratoplasty, Penetrating / Q000276:immunology*; D011239:Prednisolone / Q000008:administration & dosage; D012307:Risk Factors
chemical_list: D003907:Dexamethasone; D011239:Prednisolone
vernacular_title: Klinische Verlaufsformen immunologischer Transplantatreaktionen nach perforierender Keratoplastik.